EUVIMEDEUVIMED entdecken
Crossref

GLP-1 Receptor Agonist Therapy in Patients With Extragenital Lichen Sclerosus

Joshua Prenner, Kathryn Rentfro, Ruth Ann Vleugels, Neda Shahriari

JAMA Dermatology · 01.06.2026 · 162 (6) · 657

DOI: 10.1001/jamadermatol.2026.0476 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Dermatology, erschienen am 01.06.2026. Verfasst von Joshua Prenner und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Die Arbeit nennt 6 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This case report describes 2 patients with lichen sclerosus whose symptoms improved with glucagon-like peptide-1 receptor agonists.

Autor:innen und Institutionen

  • Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Zitieren

APA

Prenner, J., Rentfro, K., Vleugels, R. A., & Shahriari, N. (2026). GLP-1 Receptor Agonist Therapy in Patients With Extragenital Lichen Sclerosus. JAMA Dermatology, 162(6), 657. https://doi.org/10.1001/jamadermatol.2026.0476

Vancouver

Prenner J, Rentfro K, Vleugels RA, Shahriari N. GLP-1 Receptor Agonist Therapy in Patients With Extragenital Lichen Sclerosus. JAMA Dermatology. 2026;162(6):657. doi:10.1001/jamadermatol.2026.0476

BibTeX
@article{Prenner2026,
  author = {Prenner, Joshua and Rentfro, Kathryn and Vleugels, Ruth Ann and Shahriari, Neda},
  title = {GLP-1 Receptor Agonist Therapy in Patients With Extragenital Lichen Sclerosus},
  journal = {JAMA Dermatology},
  year = {2026},
  volume = {162},
  number = {6},
  pages = {657},
  doi = {10.1001/jamadermatol.2026.0476}
}
Kostenlos starten →